
Recent Articles
The Jump in Alibaba Group Holding Ltd (BABA) Stock Is Just Beginning
By
Chris Fraley, InvestorPlace Contributor
Alibaba stock has been on a nice run, but BABA could accelerate should its cloud-computing business grow the way a new report says it will.
Don’t Expect a Ford Motor Company (F) Stock Turnaround Anytime Soon
By
Chris Fraley, InvestorPlace Contributor
Ford stock has been spinning its wheels for years. Even at bargain valuations, there are no signs of a turnaround in sight for F stock.
Why Sprint Corp (S) Stock Still Looks Like a Dud
By
Chris Fraley, InvestorPlace Contributor
Sprint stock has been on fire thanks to reports of a potential deal with T-Mobile, but the rumors may not be able to prop S up much longer.
Don’t Argue, Just Buy Micron Technology Inc. (MU) Stock
By
Chris Fraley, InvestorPlace Contributor
Three more analysts have upgraded Micron (MU) stock to buy in the past few weeks, showing that MU stock is still undervalued even after a big rally.
Buy Exxon Mobil Corporation (XOM) Stock and Wait
By
Chris Fraley, InvestorPlace Contributor
Exxon Mobil (XOM) hasn't budged despite higher oil prices. For XOM stock to get going again, it will need to demonstrate growth of its own.
Twilio Inc (TWLO) Stock Is Still Stuck in Neutral
By
Chris Fraley, InvestorPlace Contributor
Twilio (TWLO) stock has yet to recover from its October and November decline. Here's why a breakout is inevitable.
Siliq Won’t Bring Valeant Pharmaceuticals Intl Inc (VRX) Stock Back to Life
By
Chris Fraley, InvestorPlace Contributor
Valeant has lost nearly all its value in the last 18 months due to its involvement with a drug called Siliq -- can it also save VRX stock?
Microsoft Corporation (MSFT) Stock Could Win Big With ‘Windows Cloud’
By
Chris Fraley, InvestorPlace Contributor
Microsoft (MSFT) has a potentially revolutionary new operating system in the works. But investors may need to see more before buying in.
Exxon Mobil Corporation (XOM) Stock’s Q4 Earnings Miss Was Priced In
By
Chris Fraley, InvestorPlace Contributor
Exxon Mobil just reported its worst quarterly earnings results in 17 years, but the damage to XOM stock has been limited. Is it time to buy?
Biogen Inc (BIIB) Stock Needs a Biotech Bounceback
By
Chris Fraley, InvestorPlace Contributor
Biogen just beat fourth-quarter earnings. But BIIB stock won't really get going until the biotech sector as a whole does.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.